Franklin, Parlapiano, Turner & Welch, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 919 filers reported holding NOVARTIS A G in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.6%.

Quarter-by-quarter ownership
Franklin, Parlapiano, Turner & Welch, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$7,834,446
-1.1%
76,914
-2.0%
2.43%
+3.4%
Q2 2023$7,922,733
+7.1%
78,513
-2.4%
2.35%
-0.2%
Q1 2023$7,397,962
+1.6%
80,413
+0.2%
2.35%
-1.4%
Q4 2022$7,279,496
+20.1%
80,241
+0.6%
2.39%
+10.7%
Q3 2022$6,063,000
-9.0%
79,768
+1.2%
2.16%
-4.1%
Q2 2022$6,662,000
-2.5%
78,813
+1.2%
2.25%
+10.7%
Q1 2022$6,834,000
+5.7%
77,877
+5.4%
2.03%
+9.5%
Q4 2021$6,463,000
+15.2%
73,891
+7.7%
1.86%
+5.4%
Q3 2021$5,609,000
-10.1%
68,590
+0.3%
1.76%
-8.7%
Q2 2021$6,237,000
+11.1%
68,363
+4.1%
1.93%
+2.2%
Q1 2021$5,615,000
-5.3%
65,685
+4.6%
1.89%
-12.2%
Q4 2020$5,929,000
+11.1%
62,788
+2.4%
2.15%
-0.2%
Q3 2020$5,335,000
+0.8%
61,345
+1.2%
2.15%
-1.6%
Q2 2020$5,293,000
+4.0%
60,606
-1.9%
2.19%
-6.4%
Q1 2020$5,091,000
-11.1%
61,752
+2.1%
2.34%
+8.3%
Q4 2019$5,726,000
+10.9%
60,472
+1.8%
2.16%
+7.4%
Q3 2019$5,163,000
-1.1%
59,412
+3.9%
2.01%
-1.8%
Q2 2019$5,223,000
-4.1%
57,196
+0.9%
2.04%
-4.8%
Q1 2019$5,448,000
+12.3%
56,668
+0.2%
2.15%
+0.7%
Q4 2018$4,853,000
+2.1%
56,553
+2.5%
2.13%
+12.4%
Q3 2018$4,753,000
+16.9%
55,160
+2.5%
1.90%
+13.2%
Q2 2018$4,066,000
-3.6%
53,830
+3.2%
1.68%
-6.7%
Q1 2018$4,217,000
-3.4%
52,158
+0.3%
1.80%
+0.5%
Q4 2017$4,367,000
+0.6%
52,010
+2.9%
1.79%
-4.1%
Q3 2017$4,341,000
+9.6%
50,561
+6.6%
1.86%
+3.0%
Q2 2017$3,960,000
+15.5%
47,439
+2.8%
1.81%
+13.7%
Q1 2017$3,428,000
+7.7%
46,151
+5.6%
1.59%
+0.8%
Q4 2016$3,182,000
-5.3%
43,683
+2.6%
1.58%
-7.5%
Q3 2016$3,361,000
+2.0%
42,568
+6.6%
1.71%
-2.8%
Q2 2016$3,295,000
+14.6%
39,930
+0.6%
1.76%
+11.0%
Q1 2016$2,875,000
-10.7%
39,686
+6.1%
1.58%
-16.9%
Q4 2015$3,218,000
-2.5%
37,400
+4.2%
1.90%
-12.2%
Q3 2015$3,299,000
-7.0%
35,891
-0.5%
2.17%
-7.6%
Q2 2015$3,548,000
+1.4%
36,076
+1.7%
2.35%0.0%
Q1 2015$3,498,000
+7.7%
35,468
+1.2%
2.35%
+8.1%
Q4 2014$3,247,000
-0.3%
35,041
+1.3%
2.17%
-7.0%
Q3 2014$3,256,000
+6.6%
34,591
+2.5%
2.34%
+6.9%
Q2 2014$3,055,000
+9.7%
33,745
+3.0%
2.18%
+8.4%
Q1 2014$2,786,000
+5.1%
32,772
-0.6%
2.02%
+10.1%
Q4 2013$2,650,000
+7.2%
32,969
+2.3%
1.83%
+1.0%
Q3 2013$2,472,000
+24.8%
32,224
+15.1%
1.81%
+7.4%
Q2 2013$1,980,000
-3.3%
27,998
-2.6%
1.69%
-1.6%
Q1 2013$2,048,000
+13.3%
28,749
+0.6%
1.72%
+2.6%
Q4 2012$1,808,00028,5651.67%
Other shareholders
NOVARTIS A G shareholders Q4 2015
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders